Xu, L., Shadman, M., Flinn, I. W., Levy, M. Y., Porter, R., Burke, J. M., Zafar, S. F., Cultrera, J. L., Misleh, J., Kingsley, E. C., Yimer, H. A., Freeman, B., Chaudhry, A., Tumula, P. K., Gandhi, M. D., Crescenzo, R., By, K., Cohen, A., Chen, D.-Y., Idoine, A., Manda, S., Sharman, J. P. and Ramakrishnan, V. (2020) “Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2023.283861.